Tag: particle therapy market growth

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

How Much Larger Will The Particle Therapy Market Become By 2030 Compared To 2026?

The particle therapy market has experienced rapid expansion in recent years. It is forecast to grow from $1.36 billion in 2025 to $1.53 billion in 2026, achieving a compound annual growth rate (CAGR) of 12.1%. Historically, this growth can be attributed to several factors such as increasing cancer incidence rates, the early adoption of proton therapy technologies, the establishment of more specialized oncology centers, a growing body of clinical evidence supporting particle therapy, and investments made by academic research hospitals.

The particle therapy market is projected for significant expansion in the coming years. This market is predicted to reach $2.44 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 12.4%. This anticipated growth is driven by several factors, including the proliferation of personalized cancer treatment methods, increased healthcare expenditure on sophisticated oncology care, the rising need for precise radiation therapies, improvements in accelerator system technology, and greater uptake in developing healthcare markets. Key developments during this period encompass the wider acceptance of pencil beam scanning systems, the increasing establishment of single-room particle therapy facilities, the expanding application of carbon ion therapy, advancements in precise treatment planning functionalities, and a heightened emphasis on pediatric oncology uses.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12250&type=smp

What Key Growth Drivers Are Influencing The Particle Therapy Market?

The expansion of the particle therapy market is anticipated to be driven by the increasing incidence of cancer. Cancer encompasses a range of intricate conditions marked by the uncontrolled multiplication and development of cells within the body. Particle therapy offers precise and potent radiation treatment for cancer, involving the acceleration of positively charged particles (protons) to high velocities and their subsequent targeting of tumors. An example illustrating this is data from April 2024 by the International Agency for Research on Cancer (IARC), a France-based intergovernmental body, which reported close to 20 million new cancer cases in 2022, leading to nearly 10 million fatalities from the illness. Projections derived from demographic patterns indicate that the yearly occurrence of new cancer diagnoses might escalate to 35 million by 2050, signifying a 77% surge compared to the 2022 statistics. Consequently, the expanding occurrence of cancer is a key factor propelling the development of the particle therapy market.

What Are The Major Segment Categories Within The Particle Therapy Market?

The particle therapy market covered in this report is segmented –

1) By Type: Proton Therapy, Heavy Ion Therapy

2) By System: Single-Room Systems, Multi-Room Systems

3) By Cancer Type: Pediatric Cancer, Prostate Cancer, Lung Cancer, Brain And Spinal Cord Cancer, Other Cancer Types

4) By End-User: Hospital, Academic And Research Centers

Subsegments:

1) By Proton Therapy: Pencil Beam Scanning Proton Therapy, Passive Scattering Proton Therapy, Intensity-Modulated Proton Therapy (IMPT)

2) By Heavy Ion Therapy: Carbon Ion Therapy, Helium Ion Therapy

What Trends Are Affecting The Particle Therapy Market Dynamics?

Leading companies within the particle therapy market are intensifying their efforts in creating groundbreaking therapies, such as the proton therapy solution, to secure a competitive advantage. Proton therapy technology represents an advanced cancer therapy employing protons and positively charged particles to administer exact and directed radiation specifically to cancerous cells. For instance, in April 2023, P-Cure, an Israel-based high-med-tech firm, was granted authorization from the United States Food and Drug Administration (USFDA) for its Adaptive Proton Therapy Solution, allowing its sales in the USA. This solution provides an affordable proton therapy technology for targeted cancer treatment with notably reduced treatment-related side effects. The P-Cure innovative upright solution is recognized as the world’s inaugural FDA-approved method for patient positioning, allowing patients to be treated while seated, which enhances both patient comfort and clinical results.

Which Companies Are Influencing The Particle Therapy Market?

Major companies operating in the particle therapy market are Hitachi Ltd., Mitsubishi Electric Corporation, Sumitomo Heavy Industries Ltd., Varian Medical Systems Inc., IBA Worldwide, Mevion Medical Systems Inc., ProNova Solutions LLC, Advanced Oncotherapy plc, Shinva Medical Instrument Co. Ltd., Optivus Proton Therapy Inc., Protom International Inc., Danfysik AS, Toshiba Energy Systems And Solutions Corporation, Canon Medical Systems Corporation, Siemens Healthineers AG, Koninklijke Philips N.V., GE Healthcare, Elekta AB, Accuray Incorporated, Xstrahl Inc.

Access The Complete Particle Therapy Market Report:

https://www.thebusinessresearchcompany.com/report/particle-therapy-global-market-report

Which Region Has The Strongest Presence In The Particle Therapy Market?

North America was the largest region in the particle therapy market in 2025. Asia-Pacific is expected to be the fastest-growing region in the particle therapy market report during the forecast period. The regions covered in the particle therapy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access a Customized Particle Therapy Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/report/particle-therapy-global-market-report

Browse Through More Reports Similar to the Global Particle Therapy Market 2026, By The Business Research Company

Proton Therapy Systems Market Report 2026

https://www.thebusinessresearchcompany.com/report/proton-therapy-systems-global-market-report

Targeted Therapy Market Report 2026

https://www.thebusinessresearchcompany.com/report/targeted-therapy-global-market-report

Nuclear Medicine Market Report 2026

https://www.thebusinessresearchcompany.com/report/nuclear-medicine-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Is The Market Size Of The Particle Therapy Market Expected To Scale Between 2026 And 2030?

The particle therapy market has seen rapid expansion in recent years. Forecasts project its expansion from $1.36 billion in 2025 to $1.53 billion in 2026, marking a compound annual growth rate (CAGR) of 12.1%. Key factors driving this historical growth include an increase in cancer incidence rates, the early adoption of proton therapy technologies, the expansion of specialized oncology centers, growing clinical evidence substantiating particle therapy, and investments from academic research hospitals.

The particle therapy market is projected for substantial expansion over the upcoming years. This market is anticipated to reach a valuation of $2.44 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 12.4%. Key drivers for this expansion during the projection period include the broader implementation of personalized cancer therapies, heightened healthcare investment in sophisticated oncology treatments, an increasing need for precise radiation techniques, continuous technological progress in accelerator systems, and a surge in uptake within developing healthcare sectors. Noteworthy trends expected over the forecast horizon encompass the wider embrace of pencil beam scanning technologies, the increasing establishment of single-room particle therapy facilities, an expanding application of carbon ion therapy, the enhancement of precise treatment planning functionalities, and a greater emphasis on applications within pediatric oncology.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/particle-therapy-global-market-report

Which Major Drivers Are Influencing The Expansion Of The Particle Therapy Market?

The increasing incidence of cancer is projected to drive the expansion of the particle therapy market moving forward. Cancer encompasses a wide range of diseases identified by the abnormal proliferation and growth of cells within the body. Particle therapy precisely and effectively treats cancer using radiation, where positively charged particles (protons) are accelerated to high speeds and then directed at the tumor. For instance, according to an April 2024 report from the International Agency for Research on Cancer (IARC), a France-based intergovernmental agency, nearly 20 million new cancer cases were reported in 2022, causing almost 10 million deaths due to the illness. Demographic trend forecasts suggest that the yearly number of new cancer cases could climb to 35 million by 2050, representing a 77% increase from the 2022 figures. Thus, the rising prevalence of cancer is a significant force propelling the growth of the particle therapy market.

Which Segments Define The Particle Therapy Market Segment Structure?

The particle therapy market covered in this report is segmented –

1) By Type: Proton Therapy, Heavy Ion Therapy

2) By System: Single-Room Systems, Multi-Room Systems

3) By Cancer Type: Pediatric Cancer, Prostate Cancer, Lung Cancer, Brain And Spinal Cord Cancer, Other Cancer Types

4) By End-User: Hospital, Academic And Research Centers

Subsegments:

1) By Proton Therapy: Pencil Beam Scanning Proton Therapy, Passive Scattering Proton Therapy, Intensity-Modulated Proton Therapy (IMPT)

2) By Heavy Ion Therapy: Carbon Ion Therapy, Helium Ion Therapy

Which Trends Are Shaping The Particle Therapy Market?

Leading companies within the particle therapy market are increasingly prioritizing the development of innovative treatments, such as proton therapy solutions, to establish a competitive advantage. Proton therapy technology serves as an advanced method for cancer treatment, utilizing protons and positively charged particles to deliver precise and targeted radiation to cancer cells. For example, in April 2023, P-Cure, an Israel-based high-med-tech company, obtained clearance from the United States Food and Drug Administration (USFDA) for its Adaptive Proton Therapy Solution, allowing its sale in the USA. This solution provides an affordable proton therapy technology for the targeted treatment of cancer, significantly reducing treatment-related side effects. P-Cure’s innovative upright solution is recognized as the world’s first FDA-approved method for patient positioning, enabling patients to receive treatment while seated, which improves patient comfort and clinical results.

Who Are The Established Players Within The Particle Therapy Market?

Major companies operating in the particle therapy market are Hitachi Ltd., Mitsubishi Electric Corporation, Sumitomo Heavy Industries Ltd., Varian Medical Systems Inc., IBA Worldwide, Mevion Medical Systems Inc., ProNova Solutions LLC, Advanced Oncotherapy plc, Shinva Medical Instrument Co. Ltd., Optivus Proton Therapy Inc., Protom International Inc., Danfysik AS, Toshiba Energy Systems And Solutions Corporation, Canon Medical Systems Corporation, Siemens Healthineers AG, Koninklijke Philips N.V., GE Healthcare, Elekta AB, Accuray Incorporated, Xstrahl Inc.

Get The Full Particle Therapy Market Report:

https://www.thebusinessresearchcompany.com/report/particle-therapy-global-market-report

Which Region Is The Leading Market For The Particle Therapy Market?

North America was the largest region in the particle therapy market in 2025. Asia-Pacific is expected to be the fastest-growing region in the particle therapy market report during the forecast period. The regions covered in the particle therapy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Particle Therapy Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/particle-therapy-global-market-report

Browse Through More Reports Similar to the Global Particle Therapy Market 2026, By The Business Research Company

Proton Therapy Systems Market Report 2026

https://www.thebusinessresearchcompany.com/report/proton-therapy-systems-global-market-report

Targeted Therapy Market Report 2026

https://www.thebusinessresearchcompany.com/report/targeted-therapy-global-market-report

Nuclear Medicine Market Report 2026

https://www.thebusinessresearchcompany.com/report/nuclear-medicine-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Is The Market Size Of The Particle Therapy Market Expected To Scale Between 2026 And 2030?

The particle therapy market has seen rapid expansion in recent years. Forecasts project its expansion from $1.36 billion in 2025 to $1.53 billion in 2026, marking a compound annual growth rate (CAGR) of 12.1%. Key factors driving this historical growth include an increase in cancer incidence rates, the early adoption of proton therapy technologies, the expansion of specialized oncology centers, growing clinical evidence substantiating particle therapy, and investments from academic research hospitals.

The particle therapy market is projected for substantial expansion over the upcoming years. This market is anticipated to reach a valuation of $2.44 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 12.4%. Key drivers for this expansion during the projection period include the broader implementation of personalized cancer therapies, heightened healthcare investment in sophisticated oncology treatments, an increasing need for precise radiation techniques, continuous technological progress in accelerator systems, and a surge in uptake within developing healthcare sectors. Noteworthy trends expected over the forecast horizon encompass the wider embrace of pencil beam scanning technologies, the increasing establishment of single-room particle therapy facilities, an expanding application of carbon ion therapy, the enhancement of precise treatment planning functionalities, and a greater emphasis on applications within pediatric oncology.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/particle-therapy-global-market-report

Which Major Drivers Are Influencing The Expansion Of The Particle Therapy Market?

The increasing incidence of cancer is projected to drive the expansion of the particle therapy market moving forward. Cancer encompasses a wide range of diseases identified by the abnormal proliferation and growth of cells within the body. Particle therapy precisely and effectively treats cancer using radiation, where positively charged particles (protons) are accelerated to high speeds and then directed at the tumor. For instance, according to an April 2024 report from the International Agency for Research on Cancer (IARC), a France-based intergovernmental agency, nearly 20 million new cancer cases were reported in 2022, causing almost 10 million deaths due to the illness. Demographic trend forecasts suggest that the yearly number of new cancer cases could climb to 35 million by 2050, representing a 77% increase from the 2022 figures. Thus, the rising prevalence of cancer is a significant force propelling the growth of the particle therapy market.

Which Segments Define The Particle Therapy Market Segment Structure?

The particle therapy market covered in this report is segmented –

1) By Type: Proton Therapy, Heavy Ion Therapy

2) By System: Single-Room Systems, Multi-Room Systems

3) By Cancer Type: Pediatric Cancer, Prostate Cancer, Lung Cancer, Brain And Spinal Cord Cancer, Other Cancer Types

4) By End-User: Hospital, Academic And Research Centers

Subsegments:

1) By Proton Therapy: Pencil Beam Scanning Proton Therapy, Passive Scattering Proton Therapy, Intensity-Modulated Proton Therapy (IMPT)

2) By Heavy Ion Therapy: Carbon Ion Therapy, Helium Ion Therapy

Which Trends Are Shaping The Particle Therapy Market?

Leading companies within the particle therapy market are increasingly prioritizing the development of innovative treatments, such as proton therapy solutions, to establish a competitive advantage. Proton therapy technology serves as an advanced method for cancer treatment, utilizing protons and positively charged particles to deliver precise and targeted radiation to cancer cells. For example, in April 2023, P-Cure, an Israel-based high-med-tech company, obtained clearance from the United States Food and Drug Administration (USFDA) for its Adaptive Proton Therapy Solution, allowing its sale in the USA. This solution provides an affordable proton therapy technology for the targeted treatment of cancer, significantly reducing treatment-related side effects. P-Cure’s innovative upright solution is recognized as the world’s first FDA-approved method for patient positioning, enabling patients to receive treatment while seated, which improves patient comfort and clinical results.

Who Are The Established Players Within The Particle Therapy Market?

Major companies operating in the particle therapy market are Hitachi Ltd., Mitsubishi Electric Corporation, Sumitomo Heavy Industries Ltd., Varian Medical Systems Inc., IBA Worldwide, Mevion Medical Systems Inc., ProNova Solutions LLC, Advanced Oncotherapy plc, Shinva Medical Instrument Co. Ltd., Optivus Proton Therapy Inc., Protom International Inc., Danfysik AS, Toshiba Energy Systems And Solutions Corporation, Canon Medical Systems Corporation, Siemens Healthineers AG, Koninklijke Philips N.V., GE Healthcare, Elekta AB, Accuray Incorporated, Xstrahl Inc.

Get The Full Particle Therapy Market Report:

https://www.thebusinessresearchcompany.com/report/particle-therapy-global-market-report

Which Region Is The Leading Market For The Particle Therapy Market?

North America was the largest region in the particle therapy market in 2025. Asia-Pacific is expected to be the fastest-growing region in the particle therapy market report during the forecast period. The regions covered in the particle therapy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Particle Therapy Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/particle-therapy-global-market-report

Browse Through More Reports Similar to the Global Particle Therapy Market 2026, By The Business Research Company

Proton Therapy Systems Market Report 2026

https://www.thebusinessresearchcompany.com/report/proton-therapy-systems-global-market-report

Targeted Therapy Market Report 2026

https://www.thebusinessresearchcompany.com/report/targeted-therapy-global-market-report

Nuclear Medicine Market Report 2026

https://www.thebusinessresearchcompany.com/report/nuclear-medicine-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Valuation Is Forecasted For The Particle Therapy Market By 2030 Starting From Its 2026 Size?

The particle therapy market size has experienced significant growth over recent years. It is projected to increase from $1.36 billion in 2025 to $1.53 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 12.1%. The expansion witnessed in the past can be ascribed to a rise in cancer incidence rates, the prompt adoption of proton therapy technologies, the development of specialized oncology centers, a growing body of clinical evidence supporting particle therapy, and financial commitments from academic research hospitals.

The particle therapy market is poised for significant expansion over the coming years. It is projected to reach $2.44 billion in 2030, exhibiting a compound annual growth rate (CAGR) of 12.4%. This anticipated growth during the forecast period is fueled by several factors, including the proliferation of personalized cancer treatment methods, increased healthcare expenditure on sophisticated oncology services, a surging demand for accurate radiation treatments, innovations in accelerator technology, and greater uptake in developing healthcare sectors. Key trends expected within this period encompass the wider implementation of pencil beam scanning systems, the expanding establishment of single-room particle therapy facilities, an increase in the utilization of carbon ion therapy, the advancement of precise treatment planning functionalities, and a heightened emphasis on pediatric oncology applications.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12250&type=smp

Which Market Drivers Are Supporting The Expansion Of The Particle Therapy Market?

The expansion of the particle therapy market is anticipated to be fueled by the increasing prevalence of cancer. Cancer refers to a diverse and complex group of diseases marked by the uncontrolled growth and proliferation of cells within the body. Particle therapy offers a precise and effective radiation treatment for cancer, involving the acceleration of positively charged particles (protons) to high speeds, which are then focused directly onto tumors. For instance, in April 2024, the International Agency for Research on Cancer (IARC), a France-based intergovernmental agency, reported that in 2022, close to 20 million new cancer cases were identified, resulting in approximately 10 million deaths from the illness. Based on demographic trends, predictions suggest that the yearly incidence of new cancer cases could rise to 35 million by 2050, indicating a 77% increase from the 2022 numbers. Consequently, the rising prevalence of cancer is a key driver for the growth of the particle therapy market.

Which Segment Categories Define The Particle Therapy Market?

The particle therapy market covered in this report is segmented –

1) By Type: Proton Therapy, Heavy Ion Therapy

2) By System: Single-Room Systems, Multi-Room Systems

3) By Cancer Type: Pediatric Cancer, Prostate Cancer, Lung Cancer, Brain And Spinal Cord Cancer, Other Cancer Types

4) By End-User: Hospital, Academic And Research Centers

Subsegments:

1) By Proton Therapy: Pencil Beam Scanning Proton Therapy, Passive Scattering Proton Therapy, Intensity-Modulated Proton Therapy (IMPT)

2) By Heavy Ion Therapy: Carbon Ion Therapy, Helium Ion Therapy

What Major Market Trends Are Driving Changes In The Particle Therapy Market?

Leading firms within the particle therapy market are intensifying their efforts to create novel treatments, including the proton therapy solution, aiming to secure a competitive advantage. This advanced cancer treatment technology employs protons and positively charged particles to precisely target and radiate cancer cells. For example, in April 2023, P-Cure, an Israel-based high-med-tech enterprise, obtained approval from the United States Food and Drug Administration (USFDA) for its Adaptive Proton Therapy Solution to be sold in the USA. This solution offers an economical proton therapy method for the precise treatment of cancer, substantially minimizing treatment-related adverse effects. P-Cure’s groundbreaking upright solution stands as the globe’s inaugural FDA-sanctioned approach for patient positioning, enabling individuals to undergo treatment while seated, thereby improving comfort and clinical outcomes.

Who Are The Top Companies Competing In The Particle Therapy Market?

Major companies operating in the particle therapy market are Hitachi Ltd., Mitsubishi Electric Corporation, Sumitomo Heavy Industries Ltd., Varian Medical Systems Inc., IBA Worldwide, Mevion Medical Systems Inc., ProNova Solutions LLC, Advanced Oncotherapy plc, Shinva Medical Instrument Co. Ltd., Optivus Proton Therapy Inc., Protom International Inc., Danfysik AS, Toshiba Energy Systems And Solutions Corporation, Canon Medical Systems Corporation, Siemens Healthineers AG, Koninklijke Philips N.V., GE Healthcare, Elekta AB, Accuray Incorporated, Xstrahl Inc.

Read the full particle therapy market report here:

https://www.thebusinessresearchcompany.com/report/particle-therapy-global-market-report

How Is The Particle Therapy Market Distributed Across Key Geographic Regions?

North America was the largest region in the particle therapy market in 2025. Asia-Pacific is expected to be the fastest-growing region in the particle therapy market report during the forecast period. The regions covered in the particle therapy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Particle Therapy Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=12250&type=smp

Browse Through More Reports Similar to the Global Particle Therapy Market 2026, By The Business Research Company

Proton Therapy Systems Market Report 2026

https://www.thebusinessresearchcompany.com/report/proton-therapy-systems-global-market-report

Targeted Therapy Market Report 2026

https://www.thebusinessresearchcompany.com/report/targeted-therapy-global-market-report

Nuclear Medicine Market Report 2026

https://www.thebusinessresearchcompany.com/report/nuclear-medicine-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Uncover key drivers, emerging technologies, and competitive movements shaping the workstation graphics processing unit (gpu) market from 2026–2035 with trusted insights from The Business Research Company

By how much is the Particle Therapy Market expected to grow between 2026 and 2030?

The particle therapy market has witnessed rapid expansion in recent years. It is projected to grow from $1.36 billion in 2025 to $1.53 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 12.1%. The historical increase in market size is largely due to factors such as rising cancer incidence rates, the early adoption of proton therapy technologies, the expansion of specialized oncology centers, increasing clinical evidence that supports particle therapy, and investments made by academic research hospitals.

The particle therapy market is projected to experience substantial expansion over the upcoming years. This market is anticipated to reach a valuation of $2.44 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 12.4%. This anticipated growth during the forecast timeframe is attributable to several factors, including the increasing availability of personalized cancer treatment methods, heightened healthcare expenditure on sophisticated oncology services, a greater need for accurate radiation treatments, innovations in accelerator technology, and wider acceptance in developing healthcare economies. Key trends foreseen during the forecast period encompass a greater uptake of pencil beam scanning systems, an increase in the establishment of single-room particle therapy facilities, the expanded application of carbon ion therapy, advancements in precise treatment planning tools, and a sharpened focus on pediatric cancer treatments.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12250&type=smp

Which Drivers Are Influencing Market Acceleration In The Particle Therapy Market?

The increasing prevalence of cancer is anticipated to fuel the expansion of the particle therapy market in the future. Cancer describes a diverse and complex set of diseases defined by the abnormal proliferation and growth of cells within the body. Particle therapy provides precise and effective radiation treatment for cancer, wherein positively charged particles, specifically protons, are accelerated to high speeds and then precisely targeted at tumors. For instance, in April 2024, reports from the International Agency for Research on Cancer (IARC), a France-based intergovernmental agency, indicated that nearly 20 million new cancer cases were documented in 2022, resulting in almost 10 million fatalities from the disease. Projections based on demographic shifts suggest that the yearly occurrence of new cancer cases could escalate to 35 million by 2050, signifying a 77% increase compared to 2022 figures. Thus, the escalating incidence of cancer is a primary driver for the growth of the particle therapy market.

What Segments Are Identified Within The Structure Of The Particle Therapy Market?

The particle therapy market covered in this report is segmented –

1) By Type: Proton Therapy, Heavy Ion Therapy

2) By System: Single-Room Systems, Multi-Room Systems

3) By Cancer Type: Pediatric Cancer, Prostate Cancer, Lung Cancer, Brain And Spinal Cord Cancer, Other Cancer Types

4) By End-User: Hospital, Academic And Research Centers

Subsegments:

1) By Proton Therapy: Pencil Beam Scanning Proton Therapy, Passive Scattering Proton Therapy, Intensity-Modulated Proton Therapy (IMPT)

2) By Heavy Ion Therapy: Carbon Ion Therapy, Helium Ion Therapy

Which Trends Are Guiding The Evolution Of The Particle Therapy Market?

Leading companies in the particle therapy market are increasingly focusing on developing innovative therapies, such as the proton therapy solution, to gain a competitive edge. Proton therapy technology is an advanced form of cancer treatment that uses protons and positively charged particles to deliver accurate and targeted radiation to cancer cells. For instance, in April 2023, P-Cure, an Israel-based high-med-tech company, received clearance from the United States Food and Drug Administration (USFDA) for its Adaptive Proton Therapy Solution for sales in the USA. This solution offers an affordable proton therapy technology for the targeted treatment of cancer with significantly reduced treatment-related side effects. The P-Cure innovative upright solution is the world’s first FDA-approved methodology for patient positioning, allowing patients to be treated while seated, which enhances both patient comfort and clinical results.

Which Key Market Players Are Investing In Expansion And Innovation Within The Particle Therapy Market?

Major companies operating in the particle therapy market are Hitachi Ltd., Mitsubishi Electric Corporation, Sumitomo Heavy Industries Ltd., Varian Medical Systems Inc., IBA Worldwide, Mevion Medical Systems Inc., ProNova Solutions LLC, Advanced Oncotherapy plc, Shinva Medical Instrument Co. Ltd., Optivus Proton Therapy Inc., Protom International Inc., Danfysik AS, Toshiba Energy Systems And Solutions Corporation, Canon Medical Systems Corporation, Siemens Healthineers AG, Koninklijke Philips N.V., GE Healthcare, Elekta AB, Accuray Incorporated, Xstrahl Inc.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/particle-therapy-global-market-report

Which Regions Are Projected To Dominate The Particle Therapy Market In The Coming Years?

North America was the largest region in the particle therapy market in 2025. Asia-Pacific is expected to be the fastest-growing region in the particle therapy market report during the forecast period. The regions covered in the particle therapy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Particle Therapy Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=12250&type=smp

Browse Through More Reports Similar to the Global Particle Therapy Market 2026, By The Business Research Company

Proton Therapy Systems Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/proton-therapy-systems-global-market-report

Targeted Therapy Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/targeted-therapy-global-market-report

Nuclear Medicine Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/nuclear-medicine-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

Uncover key drivers, emerging technologies, and competitive movements shaping the particle therapy market from 2025–2034 with trusted insights from The Business Research Company

How Big Is The Particle Therapy Market Size Today And What Will Its Value Be At The End Of 2029?

The particle therapy market size has experienced rapid expansion in recent years. This market is expected to increase from $1.23 billion in 2024 to $1.36 billion in 2025, reflecting a compound annual growth rate (CAGR) of 11.0%. The growth observed in the historical period stems from clinical research and studies, a rise in cancer incidence, government support and funding, industry collaboration, and advancements in treatment planning.

The particle therapy market is projected to experience substantial expansion over the upcoming years. By 2029, this market is anticipated to reach a valuation of $2.16 billion, demonstrating a compound annual growth rate (CAGR) of 12.3%. This projected growth during the forecast period stems from factors such as escalating healthcare spending, novel applications extending beyond oncology, an expanding elderly demographic, progress in healthcare infrastructure, and the integration of AI and data analytics. Key developments expected within this period encompass innovations in particle accelerator technology, the adoption of hypofractionation techniques, combination therapies involving protons and carbon ions, enhanced patient comfort, and treatment protocols guided by biological insights.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12250&type=smp

Which Key Drivers Are Powering Growth In The Particle Therapy Market?

The increasing occurrence of cancer is projected to drive the expansion of the particle therapy market in the future. Cancer encompasses a wide array of illnesses marked by the uncontrolled multiplication and spread of cells within the body. Particle therapy offers a precise and effective radiation treatment for cancer, utilizing positively charged particles (protons) accelerated to high velocities and directed at tumors. For example, the International Agency for Research on Cancer (IARC), a France-based, intergovernmental agency, reported in April 2024 that in 2022, approximately 20 million new cancer cases were identified, leading to almost 10 million fatalities from the condition. Demographic trend-based forecasts indicate that the yearly number of new cancer cases could reach 35 million by 2050, signifying a 77% rise compared to the 2022 statistics. Consequently, the rising incidence of cancer is a key factor propelling the growth of the particle therapy market.

Which Segment Categories Are Driving Maximum Growth In The Particle Therapy Market?

The particle therapymarket covered in this report is segmented –

1) By Type: Proton Therapy, Heavy Ion Therapy

2) By System: Single-Room Systems, Multi-Room Systems

3) By Cancer Type: Pediatric Cancer, Prostate Cancer, Lung Cancer, Breast Cancer, Brain And Spinal Cord Cancer, Other Cancer Types

4) By End-User: Hospital, Academic And Research Centers

Subsegments:

1) By Proton Therapy: Pencil Beam Scanning Proton Therapy, Passive Scattering Proton Therapy, Intensity-Modulated Proton Therapy (IMPT)

2) By Heavy Ion Therapy: Carbon Ion Therapy, Helium Ion Therapy, Other Heavy Ions

What Key Trends Are Driving Growth In The Particle Therapy Market?

A prominent trend gaining traction in the particle therapy market is the emergence of advanced particle therapy platforms. Key companies operating in the particle therapy market are innovating particle therapy platforms to maintain their competitive standing. For example, in July 2023, RaySearch Laboratories, a medical technology company based in Sweden, unveiled RayStation 2023B. This comprehensive oncology treatment planning system incorporates various innovative advancements in particle therapy, such as support for discrete proton arcs and robust optimization based on linear energy transfer (LET). LET optimization aims to minimize potential side effects by decreasing LET in organs at risk, while simultaneously directing high LET particles to tumors to improve tumor control. Furthermore, discrete proton arc optimization enables a wider spectrum of beam angles, leading to more precise dose distributions and reduced exposure for sensitive organs. The software also facilitates simple conversion to standard pencil-beam scanning plans and includes automatic field-in-field planning for photons, point-based optimization for brachytherapy, and improved data loading speeds.

Who Are The Leading Companies Driving The Particle Therapy Market?

Major companies operating in the particle therapy market include Hitachi Ltd., Mitsubishi Electric Corporation, Siemens Healthineers AG, Koninklijke Philips N.V, GE Healthcare, Sumitomo Heavy Industries Ltd., Varian Medical Systems Inc., Elekta AB, Shinva Medical Instrument Co. Ltd., Toshiba Medical Systems Corporation, Brainlab AG, Accuray Incorporated, IBA Worldwide, Mevion Medical Systems Inc., Avante Health Solutions, Provision Healthcare LLC, ViewRay, Panacea Biotec Ltd., PTW Freiburg GmbH., ProNova Solutions LLC, Optivus Proton Therapy Inc., Xstrahl Inc., Protom International Inc., Danfysik AS, SAH Global LLC, Advanced Oncotherapy plc, Particle Therapy Co-Operative Group, Best Particle Therapy Inc.

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/particle-therapy-global-market-report

Which Region Holds The Largest Share In The Particle Therapy Market Today?

North America was the largest region in the particle therapy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the particle therapy market report during the forecast period. The regions covered in the particle therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=12250&type=smp

Browse Through More Reports Similar to the Global Particle Therapy Market 2025, By The Business Research Company

Panel Filters Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/panel-filters-global-market-report

Air Compressor Filter And Compressed Air Dryer Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/air-compressor-filter-and-compressed-air-dryer-global-market-report

Filters Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/filters-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

#What Are The Current (2025) And Forecast (2029) Sizes Of The Particle Therapy Market?

The particle therapy sector has experienced substantial expansion lately, projected to increase from a valuation of $1.23 billion in 2024 to $1.36 billion a year later, reflecting an 11.0% compound annual growth rate; this historical upward trend stems from various factors including ongoing clinical investigations, a rising prevalence of cancer diagnosis, greater financial backing and encouragement from governmental bodies, enhanced cooperation within the industry, and advancements made in treatment strategy development.

Anticipation surrounds the particle therapy sector, projecting substantial expansion over the ensuing years, with its market valuation set to reach $2.16 billion by 2029, reflecting a robust compound annual growth rate of 12.3%; this upward trajectory in the projected timeframe is fueled by several factors, notably escalating spending in healthcare, novel uses emerging outside of oncology, an aging global populace, enhancements to medical infrastructure, and the incorporation of artificial intelligence alongside data analysis methodologies, while prominent developments anticipated during this forecast include progress in particle accelerator systems, the adoption of hypofractionation procedures, the synergy between proton and carbon ion treatment modalities, elevated levels of patient ease, and the refinement of treatment plans guided by biological insights.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12250&type=smp

What Are The Main Drivers Boosting The Particle Therapy Industry’s Expansion?

The increasing incidence of cancer is anticipated to fuel the expansion of the market for particle therapy as time progresses. Cancer, understood as a multifaceted and varied set of ailments defined by uncontrolled cellular development within the organism, is addressed by particle therapy largely through the administration of highly accurate and efficacious radiation; this involves speeding up particles with a positive charge, specifically protons, to significant velocities before concentrating them directly onto the cancerous mass. For example, data released in April 2024 by the International Agency for Research on Cancer (IARC), an organization established by governments and headquartered in France, indicated that approximately 20 million novel cancer diagnoses were recorded during 2022, which unfortunately led to nearly 10 million fatalities attributed to this malady. Projecting forward based on shifts in population demographics, forecasts indicate that the yearly count of new cancer diagnoses could escalate to 35 million by the year 2050, marking a substantial 77 percent jump compared to the statistics gathered in 2022, thus demonstrating that the widening scope of cancer occurrence is the primary impetus behind the particle therapy market’s upward trajectory.

What Are The Key Segments In The Particle Therapy Market?

The particle therapymarket covered in this report is segmented –

1) By Type: Proton Therapy, Heavy Ion Therapy

2) By System: Single-Room Systems, Multi-Room Systems

3) By Cancer Type: Pediatric Cancer, Prostate Cancer, Lung Cancer, Breast Cancer, Brain And Spinal Cord Cancer, Other Cancer Types

4) By End-User: Hospital, Academic And Research Centers

Subsegments:

1) By Proton Therapy: Pencil Beam Scanning Proton Therapy, Passive Scattering Proton Therapy, Intensity-Modulated Proton Therapy (IMPT)

2) By Heavy Ion Therapy: Carbon Ion Therapy, Helium Ion Therapy, Other Heavy Ions

Which Ongoing Trends Are Expected To Shape The Particle Therapy Market Outlook?

A significant development shaping the particle therapy market involves the rising prominence of sophisticated particle therapy systems, with key industry players actively introducing novel platforms to secure their market foothold. As an illustration of this trend, in July of the year 2023, RaySearch Laboratories, a firm specializing in medical technology originating from Sweden, unveiled RayStation 2023B. This complete system for oncology treatment planning incorporates several breakthroughs in particle therapy, notably incorporating assistance for segmented proton arcs and powerful optimization reliant on linear energy transfer (LET). By utilizing LET optimization, potential adverse effects are lessened through the lowering of LET within sensitive organs, while simultaneously ensuring highly aggressive LET particles are channeled towards cancerous growths to achieve superior tumor eradication. Additionally, the capacity for discrete proton arc optimization opens up numerous possibilities for beam angles, resulting in dose distributions that conform more closely to the target and diminish irradiation to critical organs. Moreover, the software enables effortless transformation into conventional pencil-beam scanning plans and offers automated field-in-field planning for photon treatments, optimization centered on specific points for brachytherapy, and accelerated data retrieval times.

Which Leading Players Are Enhancing Their Particle Therapy Market Presence Worldwide?

Major companies operating in the particle therapy market include Hitachi Ltd., Mitsubishi Electric Corporation, Siemens Healthineers AG, Koninklijke Philips N.V, GE Healthcare, Sumitomo Heavy Industries Ltd., Varian Medical Systems Inc., Elekta AB, Shinva Medical Instrument Co. Ltd., Toshiba Medical Systems Corporation, Brainlab AG, Accuray Incorporated, IBA Worldwide, Mevion Medical Systems Inc., Avante Health Solutions, Provision Healthcare LLC, ViewRay, Panacea Biotec Ltd., PTW Freiburg GmbH., ProNova Solutions LLC, Optivus Proton Therapy Inc., Xstrahl Inc., Protom International Inc., Danfysik AS, SAH Global LLC, Advanced Oncotherapy plc, Particle Therapy Co-Operative Group, Best Particle Therapy Inc.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/particle-therapy-global-market-report

What Are The Regional Market Dynamics Impacting The Particle Therapy Industry?

North America was the largest region in the particle therapy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the particle therapy market report during the forecast period. The regions covered in the particle therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Particle Therapy Market Report:

https://www.thebusinessresearchcompany.com/customise?id=12250&type=smp

Browse Through More Reports Similar to the Global Particle Therapy Market 2025, By The Business Research Company

Panel Filters Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/panel-filters-global-market-report

Air Compressor Filter And Compressed Air Dryer Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/air-compressor-filter-and-compressed-air-dryer-global-market-report

Filters Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/filters-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

How Big Is The Particle Therapy Market Today And What Is Its Future Size?

The dimension of the particle therapy market has been experiencing swift expansion of late. The market is anticipated to rise from a worth of $1.23 billion in 2024 to $1.36 billion in 2025, showing an 11.0% compound annual growth rate (CAGR). The progression noted in the historic era is due to factors such as clinical investigations and studies, rising occurrences of cancer, government backing and finances, cooperation within the industry, and enhancements in strategy for treatment.

Anticipations are high for a swift expansion in the particle therapy market size over the coming years, with forecasts suggesting it would escalate to $2.16 billion by 2029, registering a compound annual growth rate (CAGR) of 12.3%. Factors driving this projection encompass a rise in healthcare spending, the discovery of applications beyond cancer treatment, an aging population, the development of healthcare facilities, and the integration of AI and data analytics. During the forecast period, potent trends such as advancements in particle accelerator technology, hypofractionation techniques, proton and carbon ion combination therapy, enhanced patient comfort, and biology-based treatment protocols are expected to emerge.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12250&type=smp

Which Key Factors Are Fueling Growth In The Particle Therapy Market?

An upward trend in cancer incidence is predicted to stimulate the expansion of the particle therapy market. Cancer is a group of diseases characterized by abnormal cell growth and proliferation in the body. Particle therapy is primarily used to treat cancer effectively and precisely with radiation, accelerating positively charged particles (protons) to high velocities before concentrating on the tumor. For example, in April 2024, the France-based International Agency for Research on Cancer (IARC) reported that nearly 20 million new cancer cases were recorded in 2022, leading to almost 10 million fatalities. Demographic trend forecasts indicate that the yearly new cancer case rate could escalate to 35 million by 2050, signifying a 77% rise from 2022 stats. Accordingly, the increasing cancer prevalence is fuelling the particle therapy market’s expansion.

How Is The Particle Therapy Market Segmented Across Key Categories?

The particle therapymarket covered in this report is segmented –

1) By Type: Proton Therapy, Heavy Ion Therapy

2) By System: Single-Room Systems, Multi-Room Systems

3) By Cancer Type: Pediatric Cancer, Prostate Cancer, Lung Cancer, Breast Cancer, Brain And Spinal Cord Cancer, Other Cancer Types

4) By End-User: Hospital, Academic And Research Centers

Subsegments:

1) By Proton Therapy: Pencil Beam Scanning Proton Therapy, Passive Scattering Proton Therapy, Intensity-Modulated Proton Therapy (IMPT)

2) By Heavy Ion Therapy: Carbon Ion Therapy, Helium Ion Therapy, Other Heavy Ions

What Key Trends Are Driving Growth In The Particle Therapy Market?

In the particle therapy market, one significant trend picking up steam is the advancement of particle therapy platforms. To maintain their market position, dominant firms in this industry are innovating their particle therapy platform offerings. For instance, in July 2023, RaySearch Laboratories, a Sweden-based medical technology corporation, rolled out their latest offering, RayStation 2023B. This oncology treatment planning system is comprehensive and features numerous progressive developments in the realm of particle therapy. These include support for discrete proton arcs and robust optimization grounded on linear energy transfer (LET). The application of LET optimization limits potential adverse effects by lowering LET in organs at risk and directing high LET particles towards tumors for better tumor control. Additionally, optimization of discrete proton arc allows a wider range of beam angles. This results in more conformal dose distributions and a decrease in exposure for organs at risk. The software further enables an easy conversion to standard pencil-beam scanning plans, and includes automatic field-in-field planning for photons, point-based optimization for brachytherapy, and improved data loading speeds.

Who Are The Leading Companies Driving The Particle Therapy Market?

Major companies operating in the particle therapy market include Hitachi Ltd., Mitsubishi Electric Corporation, Siemens Healthineers AG, Koninklijke Philips N.V, GE Healthcare, Sumitomo Heavy Industries Ltd., Varian Medical Systems Inc., Elekta AB, Shinva Medical Instrument Co. Ltd., Toshiba Medical Systems Corporation, Brainlab AG, Accuray Incorporated, IBA Worldwide, Mevion Medical Systems Inc., Avante Health Solutions, Provision Healthcare LLC, ViewRay, Panacea Biotec Ltd., PTW Freiburg GmbH., ProNova Solutions LLC, Optivus Proton Therapy Inc., Xstrahl Inc., Protom International Inc., Danfysik AS, SAH Global LLC, Advanced Oncotherapy plc, Particle Therapy Co-Operative Group, Best Particle Therapy Inc.

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/particle-therapy-global-market-report

Which Region Dominates The Particle Therapy Market Today?

North America was the largest region in the particle therapy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the particle therapy market report during the forecast period. The regions covered in the particle therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=12250&type=smp

Browse Through More Reports Similar to the Global Particle Therapy Market 2025, By The Business Research Company

Panel Filters Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/panel-filters-global-market-report

Air Compressor Filter And Compressed Air Dryer Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/air-compressor-filter-and-compressed-air-dryer-global-market-report

Filters Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/filters-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What is the Anticipated CAGR of the Particle Therapy Market, and What Factors Will Drive It?

Over the past few years, there has been a quick expansion in the particle therapy market size. This market is projected to increase from $1.23 billion in 2024 to $1.36 billion in 2025, with a compound annual growth rate (CAGR) of 11.0%. The surge experienced in the past period is a result of factors such as clinical explorations and studies, the rise in cancer cases, governmental aid and financial backing, industry cooperation, and enhancements in treatment planning.

The market size for particle therapy is predicted to witness a significant surge in the coming years, expanding to a staggering $2.16 billion by 2029, with a Compound Annual Growth Rate (CAGR) of 12.3%. The forecast period’s growth is primarily due to more healthcare spending, new applications extending beyond cancer treatment, a growing aged population, developments in healthcare structure, as well as the integration of AI and data analytics. In the same period, noteworthy trends involve the progress in particle accelerator technology, hypofractionation strategies, the marriage of proton and carbon ion therapies, increased patient ease, and protocols directed by biological insights.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12250&type=smp

What are the Fundamental Drivers and Innovations Shaping the Particle Therapy Market?

The particle therapy market’s growth is anticipated to be fueled by the increasing incidence of cancer. Cancer is defined as a diverse and complex set of diseases involving abnormal cell growth and proliferation within the body. The primary treatment method of particle therapy involves using accurate and effective radiation where protons, which are positively charged particles, are accelerated at high velocities and focused on the tumor. As an example, the International Agency for Research on Cancer (IARC), a France-based intergovernmental organization, reported that there were close to 20 million new cancer cases in 2022, leading to almost 10 million fatalities. Future estimates based on demographic forecasts project that the number of new annual cancer cases could elevate to 35 million by 2050. This is a staggering 77% surge from the statistics of 2022. This escalating incidence of cancer is fueling the expansion of the particle therapy market.

How Is the Particle Therapy Market Segmented?

The particle therapymarket covered in this report is segmented –

1) By Type: Proton Therapy, Heavy Ion Therapy

2) By System: Single-Room Systems, Multi-Room Systems

3) By Cancer Type: Pediatric Cancer, Prostate Cancer, Lung Cancer, Breast Cancer, Brain And Spinal Cord Cancer, Other Cancer Types

4) By End-User: Hospital, Academic And Research Centers

Subsegments:

1) By Proton Therapy: Pencil Beam Scanning Proton Therapy, Passive Scattering Proton Therapy, Intensity-Modulated Proton Therapy (IMPT)

2) By Heavy Ion Therapy: Carbon Ion Therapy, Helium Ion Therapy, Other Heavy Ions

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=12250&type=smp

Which Regions Are Driving the Next Phase of the Particle Therapy Market Growth?

North America was the largest region in the particle therapy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the particle therapy market report during the forecast period. The regions covered in the particle therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Key Trends Are Shaping the Future of the Particle Therapy Market?

In the particle therapy market, the rise of sophisticated particle therapy platforms is a notable trend. Major businesses in this market are creating unique particle therapy systems to maintain their market status. For example, a medical technology company located in Sweden, RaySearch Laboratories, introduced RayStation 2023B in July 2023. This full oncology treatment planning system offers multiple pioneering features in particle therapy, such as standalone proton arc support and a robust optimization that relies on linear energy transfer (LET). The potential side effects are minimized using LET optimization as it reduces LET in risk organs, while directing high LET particles to tumors for better control. The optimization of discrete proton arcs allows for a wider range of beam angles, resulting in more conformal dose distributions and decreased exposure for risk organs. Additionally, the software allows for easy conversion to standard pencil-beam scanning plans and includes automatic field-in-field planning for photons, point-based optimization for brachytherapy, and quicker data loading times.

View the full report here:

https://www.thebusinessresearchcompany.com/report/particle-therapy-global-market-report

How Is the Particle Therapy Market Defined and What Are Its Core Parameters?

Particle therapy is a specialized cancer treatment that utilizes charged particles, such as protons or heavier ions, to deliver radiation therapy to cancerous tumors. Particle therapy mainly treats cancer by aiming for energetic ionizing particles at the tumor site. Its goal is to enhance treatment results for patients with different types of tumors, especially those that are challenging to address with standard radiation therapy.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12250

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has the Particle Therapy Market Size Changed, over the years?

In recent times, there has been significant growth in the size of the particle therapy market. Expected to expand from $1.23 billion in 2024 to $1.37 billion in 2025, the market will see a compound annual growth rate (CAGR) of 11.8%. The factors contributing to this growth in the historical period include clinical research and studies, a rise in cancer rates, government backing and funding, industry synergy, and enhancements in treatment planning.

How Much Will the Particle Therapy Market Be Worth in 2029?

Expectations are high for the particle therapy market as it is predicted to experience swift expansion in the coming years. By 2029, the market is anticipated to reach a value of $2.19 billion, with a Compound Annual Growth Rate (CAGR) of 12.4%. Several factors contribute to this projected growth within the forecast period, including an increase in healthcare spending, emerging applications extending beyond the scope of cancer, a growing elderly population, advances in healthcare infrastructure, and the integration of AI and data analytics. Some noteworthy trends in this forecast period encompass developments in particle accelerator technology, hypofractionation techniques, combined proton and carbon ion therapy, enhanced patient comfort, and biology-driven treatment models.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12250&type=smp

Which is the Largest Company in the Particle Therapy Market?

Major companies operating in the particle therapy market include Hitachi Ltd., Mitsubishi Electric Corporation, Siemens Healthineers AG, Koninklijke Philips N.V, GE Healthcare, Sumitomo Heavy Industries Ltd., Varian Medical Systems Inc., Elekta AB, Shinva Medical Instrument Co. Ltd., Toshiba Medical Systems Corporation, Brainlab AG, Accuray Incorporated, IBA Worldwide, Mevion Medical Systems Inc., Avante Health Solutions, Provision Healthcare LLC, ViewRay, Panacea Biotec Ltd., PTW Freiburg GmbH., ProNova Solutions LLC, Optivus Proton Therapy Inc., Xstrahl Inc., Protom International Inc., Danfysik AS, SAH Global LLC, Advanced Oncotherapy plc, Particle Therapy Co-Operative Group, Best Particle Therapy Inc.

What Are the Main Market Drivers in the Particle Therapy Industry?

The escalating incidence of cancer is predicted to fuel the expansion of the particle therapy market. Cancer is a diverse and intricate cluster of diseases marked by abnormal cell growth and multiplication in the body. Particle therapy is primarily used to treat cancer effectively and accurately with radiation, whereby positively charged particles (protons) are expedited to high velocities and then targeted on the tumor. For instance, as per the International Agency for Research on Cancer (IARC), a France-based, intergovernmental agency, in 2022, close to 20 million fresh cases of cancer were documented, resulting in nearly 10 million deaths due to the disease. Forecasts grounded on demographic trends indicate that the annual rate of fresh cancer cases could escalate to 35 million by 2050, signifying a 77% surge from the 2022 statistics. Therefore, the ascending incidence of cancer is propelling the expansion of the particle therapy market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=12250&type=smp

How Is the Particle Therapy Market Segments Structured?

The particle therapy market covered in this report is segmented –

1) By Type: Proton Therapy, Heavy Ion Therapy

2) By System: Single-Room Systems, Multi-Room Systems

3) By Cancer Type: Pediatric Cancer, Prostate Cancer, Lung Cancer, Breast Cancer, Brain And Spinal Cord Cancer, Other Cancer Types

4) By End-User: Hospital, Academic And Research Centers

Subsegments:

1) By Proton Therapy: Pencil Beam Scanning Proton Therapy, Passive Scattering Proton Therapy, Intensity-Modulated Proton Therapy (IMPT)

2) By Heavy Ion Therapy: Carbon Ion Therapy, Helium Ion Therapy, Other Heavy Ions

What Strategic Trends Are Transforming the Particle Therapy Market?

There is an increasing trend towards the adoption of advanced particle therapy platforms in the particle therapy market. Significant players in this market are strategically innovating these platforms to maintain their foothold. For instance, in the month of July 2023, RaySearch Laboratories, a firm based in Sweden that specializes in medical technology, introduced RayStation 2023B. This novel system for oncology treatment planning brings numerous new progressions in particle therapy, such as the capacity for discrete proton arcs and potent optimization grounded on linear energy transfer (LET). The principle of LET optimization is to decrease possible side effects by lowering LET in organs at risk, while simultaneously guiding high LET particles towards tumors to enhance tumor control. Also, unique discrete proton arc optimization allows for a wider selection of beam angles, resulting in conformal dose distributions and diminishing exposure for organs at risk. The software simplifies the transition to standard pencil-beam scanning plans and integrates automatic field-in-field planning for photons, point-optimized planning for brachytherapy, and upgraded data loading speeds.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/particle-therapy-global-market-report

Which Global Regions Offer the Highest Growth in the Particle Therapy Market?

North America was the largest region in the particle therapy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the particle therapy market report during the forecast period. The regions covered in the particle therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12250

This Report Delivers Insight On:

1. How big is the particle therapy market, and how is it changing globally?

2. Who are the major companies in the particle therapy market, and how are they performing?

3. What are the key opportunities and risks in the particle therapy market right now?

4. Which products or customer segments are growing the most in the particle therapy market?

5. What factors are helping or slowing down the growth of the particle therapy market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model